MAPT and tauopathy: Additionally, studies have associated tau pathology with LRRK2 mutations (Henderson et al., 2019, Zimprich et al., 2004) whilst another study demonstrated that LRRK2 phosphorylates tau and promotes tauopathy (Bailey et al., 2013).